ProShare Advisors’s Verona Pharma VRNA Stock Holding History

ProShare Advisors’s Portfolio VRNA Stock Details VRNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-5,676	Closed	-$606K	–	2093
2025 Q3	$606K	Buy	5,676 +2,738	+93%	+$286K	﹤0.01%	1018
2025 Q2	$278K	Sell	2,938 -617	-17%	-$45.7K	﹤0.01%	1500
2025 Q1	$226K	Buy	+3,555	New	+$213K	﹤0.01%	1609

Other funds holding VRNA

DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return

ProShare Advisors's VRNA Position: Q4 2025 in Review

ProShare Advisors sold out of Verona Pharma (VRNA) in Q4 2025, closing a stake of 5,676 shares — an estimated $606K sold.

ProShare Advisors first reported a position in VRNA in Q1 2025 and held it in 3 quarters. The position peaked at $606K in Q3 2025. 1 fund tracked by Wall St. Rank holds VRNA as of Q4 2025.

ProShare Advisors reported no remaining Verona Pharma position as of Q4 2025 after selling out during the quarter.
ProShare Advisors sold 5,676 Verona Pharma shares in Q4 2025, an estimated $606K.
ProShare Advisors first reported a position in Verona Pharma in Q1 2025 and held it in 3 quarters.
ProShare Advisors's Verona Pharma position peaked at $606K in Q3 2025.
1 fund tracked by Wall St. Rank held Verona Pharma as of Q4 2025.

Based on ProShare Advisors's 13F filing for Q4 2025, filed 6 Feb 2026.